The role of GnRH analogues in the treatment of endometriosis

No abstract is available for this paper.

• Publication year

  1992

• Venue

  British Journal of Obstetrics and Gynaecology

• Publication date

  1992-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1471-0528.1992.tb13532.xPMID 1554688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Classification of endometriosis.

  1993cited by this paper
• GnRH analogues in the treatment of endometriosis — rationale and efficacy

  1991cited by this paper
• Treatment of Endometriosis With a Long-Acting Gonadotropin-Releasing Hormone Agonist Plus Medroxyprogesterone Acetate

  1990cited by this paper
• THE EFFECTS OF NAFARELIN AND DANAZOL ON VERTEBRAL TRABECULAR BONE MASS IN PATIENTS WITH ENDOMETRIOSIS

  1990cited by this paper
• The effects of combining norethindrone with a gonadotropin‐releasing hormone agonist in the treatment of symptomatic endometriosis

  1990cited by this paper
• Circulating lipid and lipoprotein concentrations during danazol and high‐dose medroxyprogesterone acetate therapy of endometriosis

  1990cited by this paper
• Circulating lipid and lipoprotein concentrations during danazol and high-dose medroxyprogesterone acetate therapy of endometriosis *

  1989cited by this paper
• Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol.

  1989cited by this paper
• REVERSIBLE TRABECULAR BONE DENSITY LOSS FOLLOWING INDUCED HYPO‐OESTROGENISM WITH THE GnRH ANALOGUE BUSERELIN IN PREMENOPAUSAL WOMEN

  1988cited by this paper
• The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism.

  1988cited by this paper
• Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol.

  1988cited by this paper
• Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial.

  1988cited by this paper
• LHRH analogues and bone loss.

  1987cited by this paper
• Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.

  1987cited by this paper
• Revised American Fertility Society classification of endometriosis: 1985

  1985cited by this paper
• Revised American Fertility Society classification of endometriosis: 1985.

  1985cited by this paper
• Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis.

  1984cited by this paper
• Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.

  1983cited by this paper
• Ulceration of the hand secondary to a radial arteriovenous fistula: a model for varicose ulceration.

  1983cited by this paper
• Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up

  1982cited by this paper
• "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis.

  1982cited by this paper
• Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up.

  1982cited by this paper

• Erkrankungen des Uterus

  2021cites this paper
• Endometriose Endometriose – Entstehung , Diagnostik , Behandlungsmöglichkeiten und Probleme in Klinik und Praxis

  2019cites this paper
• Medical treatment of ureteral obstruction associated with ovarian remnants and/or endometriosis: report of three cases and review of the literature.

  2015cites this paper
• Endometriosis – Pathogenesis, Diagnosis, and Therapeutic Options for Clinical and Ambulatory Care

  2013cites this paper
• Frequency of Mycoplasma hominis and Ureaplasma urealyticum in Females With Urogenital Infections and Habitual Abortion History in Ahvaz, Iran; Using Multiplex PCR

  2013cites this paper
• 2-Methoxyestradiol in the Pathophysiology of Endometriosis: Focus on Angiogenesis and Therapeutic Potential

  2012cites this paper
• Endometriose - Entstehung, Diagnostik, Behandlungsmöglichkeiten und Probleme in Klinik und Praxis

  2011cites this paper
• Current pharmacotherapy for endometriosis

  2010cites this paper
• An investigation of the surgical treatment of endometriosis

  2010cites this paper
• Non-steroidal anti-inflammatory drugs

  2010cites this paper
• Manic and psychotic symptoms following subcutaneous leuprolide in a male patient with no prior psychiatric history.

  2010cites this paper
• The non-human primate model of endometriosis: research and implications for fecundity.

  2009cites this paper
• KAPITEL 11 – Erkrankungen des Uterus

  2008cites this paper
• J 3 – Endometriose

  2007cites this paper
• GnRH-Analoga in der Endometriosetherapie

  2006cites this paper
• Surgical management of ovarian endometrioma: cystectomy by stripping of the capsule

  2005cites this paper
• Leitlinien für den Einsatz der GnRH-Agonisten zur Behandlung der Endometriose

  2005cites this paper
• Treatment of Ovarian Endometrioma

  2003cites this paper
• Diagnosis and treatment of endometriosis

  2003cites this paper
• Ureteral endometriosis.

  2003cites this paper
• CONTROVERSIAS EN EL MANEJO QUIRÚRGICO DEL ENDOMETRIOMA OVÁRICO

  2002cites this paper
• Laparoscopic Treatment of Endometrioma-Associated Infertility and Pregnancy Outcome

  2002cites this paper
• Menstrual Migraine

  1999cites this paper
• Reoperation after laparoscopic treatment of ovarian endometriomas by excision and by fenestration.

  1999cites this paper
• GnRH agonists and add‐back therapy: is there a perfect combination?

  1998cites this paper
• The Role of GnRH Agonists Plus Add-Back Therapy in the Treatment of Endometriosis

  1997cites this paper
• Retroperitoneal endometriosis causing cyclical ureteral obstruction.

  1996cites this paper
• Natural Cytotoxicity and GnRH Agonist Administration in Advanced Endometriosis: Positive Modulation on Natural Killer Activity

  1996cites this paper
• Large ovarian endometriomas.

  1996cites this paper
• Long-term gonadotropin-releasing hormone agonist therapy: the evolving issue of steroidal "add-back" paradigms.

  1995cites this paper
• Hormonal regulation of endometriosis and the rationales and effects of gonadotrophin-releasing hormone agonist treatment: a review.

  1995cites this paper
• Electrocauterization in rats of experimentally induced endometriosis at a low temperature.

  1995cites this paper
• Danazol suspension injected into the uterine cervix of patients with adenomyosis and myoma. Preliminary study.

  1995cites this paper
• Long-term gonadotrophin-releasing hormone agonist therapy: the evolving issue of steroidal 'add-back' paradigms.

  1994cites this paper
• Multiple gestation following gonadotrophin releasing hormone therapy for the treatment of minimal endometriosis

  1994cites this paper
• Thinning the endometrium prior to ablation: is it worthwhile?

  1994cites this paper
• The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade

  1994cites this paper
• Miscellaneous hormones and prostaglandins

  1994cites this paper
• Principles of medical therapy for endometriosis pain

  1992cites this paper
• Report on a conference on developments in the treatment of benign gynecological disorders.

  1992cites this paper
• Reproduktionsmedizin und Endokrinologie

  year unknowncites this paper